4 replies to this topic

[sub7]

Unless I missed it, this has not been discussed

 

https://newsramp.com...690aed4eec003a8

 

Any idea at all what the drug might be? No mention of what it is, what MOA it has and what the mode of administration is...

[simon007]

I found this

https://www.pharmain...maceuticals-inc

and

https://www.sec.gov/...696/forms-1.htm

 

See https://www.google.c...r-1 ingredients

Edited by simon007, 04 September 2024 - 12:57 PM.

[sub7]

Thanks a ton

In the first link you provided, he first talks how Telomir-1 extends telomeres and then says this too

 

Telomir-1 reversibly binds to essential metals preventing the ionization of those metals due to the Fenton reaction and therefore limiting their biological effects. Age-related diseases such as osteoarthritis, senile dementia, macular degeneration, hemochromatosis, and muscle wasting are just some of the potential applications. Although metal reactivity is required for eukaryotic organisms to reach healthy maturity, continued elevated and unregulated metal-induced enzymatic activity contributes to oxidation and inflammation. It has long been recognized that enzymatic reactions also play a key role in the formation of cancerous mutations and the development of diseases like hemochromatosis. By limiting available metals, thus inhibiting metal-induced enzymatic activity, Telomir-1 may prove to be an effective platform for treating a variety of diseases.

 

So  does this drug do 2 totally unrelated things -as in extend telomeres and bind to metals???

[sub7]

 

See https://www.google.c...r-1 ingredients

 

So do we know what the ingredient is?

BTW it says orally dosed...

[QuestforLife]

Thanks a ton

In the first link you provided, he first talks how Telomir-1 extends telomeres and then says this too

 

Telomir-1 reversibly binds to essential metals preventing the ionization of those metals due to the Fenton reaction and therefore limiting their biological effects. Age-related diseases such as osteoarthritis, senile dementia, macular degeneration, hemochromatosis, and muscle wasting are just some of the potential applications. Although metal reactivity is required for eukaryotic organisms to reach healthy maturity, continued elevated and unregulated metal-induced enzymatic activity contributes to oxidation and inflammation. It has long been recognized that enzymatic reactions also play a key role in the formation of cancerous mutations and the development of diseases like hemochromatosis. By limiting available metals, thus inhibiting metal-induced enzymatic activity, Telomir-1 may prove to be an effective platform for treating a variety of diseases.

 

So  does this drug do 2 totally unrelated things -as in extend telomeres and bind to metals???

 

Annoyingly, the article make certain claims about telomere lengthening and telomerase activity increases, but it is rather vague and no plots are given. If it increases telomerase activity, then what is this bench marked against, given they are examining telomerase negative cells?

 

Given the claimed mechanism of action, it appears whatever benefit this substance may have on cells, it is not via telomerase activation. The whole thing smells of BS (this is the first substance that increases telomerase, etc, etc.).

But it is worth keeping a watching brief on in case I am wrong...